FIRST RESULTS OF THE RANDOMIZED PHASE II TAVAREC TRIAL ON TEMOZOLOMIDE WITH OR WITHOUT BEVACIZUMAB IN 1P/19Q INTACT 1ST RECURRENCE GRADE II AND III GLIOMA

Author(s):
Idbaih, A.; Clement, P.M.; Vos, F.Y.F.; Platten, M.; Mulholland, P.; Taphoorn, M.J.B.; Lewis, L.; Golfinopoulos, V.; Gorlia, T.; Bent, M.J. van den
Published
2016
Publication type
Article / Letter to editor
Date issued
2016-10-31
Language
English
Is part of
Neuro-Oncology (2016), Vol. 18, p. 13-13
hdl
1887/113088